Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $492.11 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $170.76 | 4 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $136.11 | 2 | $0 (2019) |
| Amgen Inc. | $94.00 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $38.44 | 1 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $26.41 | 1 | $0 (2018) |
| DePuy Synthes Sales Inc. | $26.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $187.18 | 4 | Dendreon Pharmaceuticals LLC ($136.11) |
| 2018 | $120.41 | 2 | Amgen Inc. ($94.00) |
| 2017 | $184.52 | 4 | Allergan Inc. ($158.13) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $101.09 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/05/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $38.44 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/29/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $94.00 | General |
| 04/17/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $26.41 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 10/12/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $128.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2017 | Allergan Inc. | BOTOX THERAPEUTIC - HH (Biological) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/18/2017 | DePuy Synthes Sales Inc. | LIFENET VIVIGEN (Device) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Spine | ||||||
| 02/14/2017 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
About Dr. Dominique Lash, M.D
Dr. Dominique Lash, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Sylvania, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265493431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dominique Lash, M.D has received a total of $492.11 in payments from pharmaceutical and medical device companies, with $187.18 received in 2019. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($492.11).
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Sylvania, OH
- Active Since 03/29/2006
- Last Updated 07/21/2022
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265493431
Products in Payments
- PROVENGE (Drug) $136.11
- BOTOX NEURO REHAB (Drug) $128.07
- XTANDI (Drug) $38.44
- BOTOX (Biological) $31.78
- BEVYXXA (Drug) $26.41
- LIFENET VIVIGEN (Device) $26.39
- BOTOX THERAPEUTIC - HH (Biological) $10.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.